Publications

Found 13 results
Filters: Keyword is Nanostructures  [Clear All Filters]
2018
Willegems, K., and R. G. Efremov, "Influence of Lipid Mimetics on Gating of Ryanodine Receptor.", Structure, vol. 26, issue 10, pp. 1303-1313.e4, 2018 10 02.
2017
Efremov, R. G., C. Gatsogiannis, and S. Raunser, "Lipid Nanodiscs as a Tool for High-Resolution Structure Determination of Membrane Proteins by Single-Particle Cryo-EM.", Methods Enzymol, vol. 594, pp. 1-30, 2017.
2012
Baranova, E., R. Fronzes, A. Garcia-Pino, N. Van Gerven, D. Papapostolou, G. Péhau-Arnaudet, E. Pardon, J. Steyaert, S. Howorka, and H. Remaut, "SbsB structure and lattice reconstruction unveil Ca2+ triggered S-layer assembly.", Nature, vol. 487, issue 7405, pp. 119-22, 2012 Jul 5.
Caljon, G., V. Caveliers, T. Lahoutte, B. Stijlemans, G. H. Ghassabeh, J. Van Den Abbeele, I. Smolders, P. De Baetselier, Y. Michotte, S. Muyldermans, et al., "Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier.", Br J Pharmacol, vol. 165, issue 7, pp. 2341-53, 2012 Apr.
2011
Gainkam, L. Olive Tcho, M. Keyaerts, V. Caveliers, N. Devoogdt, C. Vanhove, L. Van Grunsven, S. Muyldermans, and T. Lahoutte, "Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy.", Mol Imaging Biol, vol. 13, issue 5, pp. 940-8, 2011 Oct.
Hassanzadeh-Ghassabeh, G., D. Saerens, and S. Muyldermans, "Generation of anti-infectome/anti-proteome nanobodies.", Methods Mol Biol, vol. 790, pp. 239-59, 2011.
Van de Broek, B., N. Devoogdt, A. D'Hollander, H-L. Gijs, K. Jans, L. Lagae, S. Muyldermans, G. Maes, and G. Borghs, "Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy.", ACS Nano, vol. 5, issue 6, pp. 4319-28, 2011 Jun 28.
Rasmussen, S. G. F., H-J. Choi, J. Jose Fung, E. Pardon, P. Casarosa, P. Seok Chae, B. T. Devree, D. M. Rosenbaum, F. Sun Thian, T. Sun Kobilka, et al., "Structure of a nanobody-stabilized active state of the β(2) adrenoceptor.", Nature, vol. 469, issue 7329, pp. 175-80, 2011 Jan 13.
2008
Saerens, D., K. Conrath, J. Govaert, and S. Muyldermans, "Disulfide bond introduction for general stabilization of immunoglobulin heavy-chain variable domains.", J Mol Biol, vol. 377, issue 2, pp. 478-88, 2008 Mar 21.
2006
Baral, T. Nath, S. Magez, B. Stijlemans, K. Conrath, B. Vanhollebeke, E. Pays, S. Muyldermans, and P. De Baetselier, "[Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor].", Med Sci (Paris), vol. 22, issue 11, pp. 914-6, 2006 Nov.
2005
Huysmans, G., A. Ranquin, L. Wyns, J. Steyaert, and P. Van Gelder, "Encapsulation of therapeutic nucleoside hydrolase in functionalised nanocapsules.", J Control Release, vol. 102, issue 1, pp. 171-9, 2005 Jan 20.
Revets, H., P. De Baetselier, and S. Muyldermans, "Nanobodies as novel agents for cancer therapy.", Expert Opin Biol Ther, vol. 5, issue 1, pp. 111-24, 2005 Jan.
Ranquin, A., W. Versées, W. Meier, J. Steyaert, and P. Van Gelder, "Therapeutic nanoreactors: combining chemistry and biology in a novel triblock copolymer drug delivery system.", Nano Lett, vol. 5, issue 11, pp. 2220-4, 2005 Nov.